Derangere V, Lecuelle J, Lepage C, Salem OA, et al. Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049]. Eur J Cancer 2026;239:116586.
PMID: 41946180